Roche Diagnostics Corp.

FDA Regulatory Profile

Summary

Total Recalls
0
510(k) Clearances
452
Inspections
24
Compliance Actions
0

Known Names

roche diagnostics, roche diagnostics operations, roche diagnostics corporation

Recent 510(k) Clearances

K-NumberDeviceDate
K252323cobas pulse blood glucose monitoring systemJune 12, 2026
K252431Elecsys CalcitoninApril 24, 2026
K252280Elecsys Anti-SARS-CoV-2 SApril 13, 2026
K260048Elecsys Anti-HAV IgMApril 7, 2026
K260046Elecsys Anti-HBc IIApril 7, 2026
K260049Elecsys Anti-HBc IgMApril 7, 2026
K260026Tina-quant Cardiac high sensitivity CRP IIIApril 2, 2026
K253490Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsFebruary 12, 2026
K253491ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integratedFebruary 12, 2026
K253839Elecsys Anti-SARS-CoV-2December 17, 2025
K253188CoaguChek XS Plus SystemOctober 24, 2025
K252163Elecsys Phospho-Tau (181P) PlasmaOctober 8, 2025
K242505Elecsys Cortisol IIIJuly 17, 2025
K250768Elecsys Anti-SARS-CoV-2June 10, 2025
K241453Elecsys sFlt-1 and Elecsys PlGFFebruary 7, 2025
K233060Elecsys Folate IIIJune 17, 2024
K220272cobas pulse blood glucose monitoring systemApril 26, 2024
K231927Elecsys PTH , Elecsys PTH STATMarch 22, 2024
K221890Elecsys Tg IISeptember 30, 2023
K222610Elecsys Anti-TgSeptember 15, 2023